Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pentynoic acid derivatives revealed by ABS and the University College Dublin

May 31, 1996

American Home Product reveals M1 receptor agonist

May 31, 1996

RPR's riluzole prolongs survival in large international trial

May 31, 1996

CCD-3693 marketing agreement announced by CoCensys and Searle

May 31, 1996

Hyal's 3% diclofenac gel: Positive phase III results announced

May 31, 1996

Shanghai Institute of Materia Medica reveals epibatidine analogue

May 31, 1996

New bradykinin antagonists from Sanofi Winthrop

May 31, 1996

Astra reveals analgesic and immunosuppressive agents

May 31, 1996

HMR discloses 5-HT reuptake inhibitors

May 24, 1996

Sankyo's calpain inhibitor for neurological disorders, restenosis

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...